A Phase Ii Study of THP (Pirarubicin)-Cop Therapy in Patients With Newly Diagnosed Advanced Ptcl: THP-3 Study of Japan Hematopoietic Malignancy Clinical Study Group

Hematological Oncology - United Kingdom
doi 10.1002/hon.147_2631

Related search